Introduction

In recent years, a new paradigm has emerged in oncology and longevity medicine:

👉 targeting cancer through its metabolism rather than only through cytotoxicity.Two central metabolic fuels sustain many tumors:

• Glucose (via aerobic glycolysis – the Warburg effect)
• Glutamine (for mitochondrial function and biosynthesis)

This has led to growing interest in interventions that simultaneously disrupt both pathways.Among these, the combination of:

• Fasting-Mimicking Diet
• Hyperbaric Oxygen Therapy

offers a non-pharmacological, systems-based approach to metabolic targeting.

The Metabolic Vulnerability of Cancer

4Cancer cells often exhibit:

• High dependence on glucose fermentation (Warburg effect)
• Increased reliance on glutamine metabolism (glutaminolysis)
• Dysfunctional or stressed mitochondria
• A hypoxic microenvironment

These features create a paradox:

👉 Cancer cells are highly adaptable, yet metabolically fragile under coordinated stress

The Role of FMD: Systemic Metabolic Reprogramming

The FMD, pioneered by Valter Longo, is a low-calorie, low-protein, plant-based protocol designed to mimic fasting while maintaining safety and compliance.

Key metabolic effects:

• ↓ Blood glucose
• ↓ Insulin and IGF-1
• ↓ mTOR activation
• ↓ Protein intake → ↓ glutamine availability
• ↑ Ketogenesis and metabolic flexibility

👉 Result:

• Reduced fuel availability (glucose)
• Reduced growth signaling (IGF-1 / mTOR)
• Lower demand and partial restriction of glutamine pathways

Importantly, FMD induces a state of differential stress resistance:

• Healthy cells → enter protective mode
• Cancer cells → remain vulnerable

📚 Key references:

• Longo VD & Mattson MP. Cell Metabolism, 2014
• Brandhorst S et al. Cell Metabolism, 2015

The Role of HBOT: Oxygen as a Metabolic Stressor

HBOT (typically 2 ATA, 60–120 min) dramatically increases oxygen dissolved in plasma.

Biological effects:

• Reverses tumor hypoxia
• Forces cells toward oxidative metabolism
• Increases reactive oxygen species (ROS)
• Enhances mitochondrial activity

👉 Cancer cells—often reliant on glycolysis—struggle under these conditions.

Synergy: FMD + HBOT

The combination creates a dual metabolic pressure:

1. Fuel restriction (FMD)

• ↓ Glucose
• ↓ Glutamine signaling

2. Oxidative stress (HBOT)

• ↑ ROS
• ↑ Mitochondrial demand

The key insight

Cancer cells are pushed into a metabolic “trap”:

• Glucose is limited
• Glutamine pathways are constrained
• Oxygen forces mitochondrial respiration
• ROS levels increase

👉 This reduces metabolic flexibility, a hallmark of cancer survival.

The Perspective of Thomas Seyfried

Thomas Seyfried has been a leading advocate of the metabolic theory of cancer, arguing that:

Cancer is fundamentally a disease of mitochondrial dysfunction and altered energy metabolism.

He emphasizes:

• Targeting glucose and glutamine simultaneously
• Using non-toxic metabolic therapies
• Combining dietary strategies with oxidative stressors

📚 Key references:

• Seyfried TN. Cancer as a Metabolic Disease, 2012
• Seyfried et al. Nutrition & Metabolism, 2020

Why This Approach May Be Superior to Glutamine Blockers

Pharmacological glutamine inhibition (e.g., GLS inhibitors like CB-839) has gained attention. However, it presents several limitations:

1. Systemic toxicity and narrow targeting

Glutamine is essential for:

• Gut integrity
• Immune function
• Nitrogen balance

👉 Blocking it pharmacologically can:

• Impair immunity
• Damage healthy tissues

2. Metabolic compensation

Cancer cells can adapt by:

• Switching fuels (fatty acids, lactate, ketones)
• Increasing glucose uptake

👉 Single-pathway blockade often fails

3. Lack of systemic context

Drugs target enzymes but not the whole metabolic environment

In contrast: FMD + HBOT

Key advantage

👉 Instead of “blocking glutamine,”

you reduce its relevance and effectiveness

• ↓ intake (FMD)
• ↓ signaling (mTOR)
• ↑ oxidative stress (HBOT)

➡️ Cancer cells cannot compensate easily

Differential Stress: Protecting Healthy Cells

One of the most compelling aspects of this approach:

• Healthy cells:
  • Activate repair pathways
  • Increase antioxidant defenses
• Cancer cells:
  • Remain metabolically inflexible
  • Accumulate damage

👉 This creates a therapeutic window without direct toxicity

Limitations and Considerations

• Clinical evidence is still emerging
• Not all tumors respond equally
• Protocols must be personalized
• Should be used as an adjunct, not a replacement for standard care

Conclusion

The combination of:

• Fasting-Mimicking Diet (FMD)
• Hyperbaric Oxygen Therapy (HBOT)

represents a systems biology approach to cancer metabolism.Rather than targeting a single pathway, it:

• Reduces glucose availability
• Modulates glutamine utilization
• Increases oxidative stress
• Limits metabolic flexibility

👉 Aligning closely with the metabolic framework proposed by Thomas Seyfried

Final Insight

The future of oncology may not lie in stronger drugs,
but in smarter metabolic environments.

📚 Selected References

1. Longo VD, Mattson MP. Fasting: Molecular mechanisms and clinical applications. Cell Metabolism, 2014
2. Brandhorst S et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration. Cell Metabolism, 2015
3. Seyfried TN. Cancer as a Metabolic Disease. Wiley, 2012
4. Seyfried TN et al. Metabolic therapy: A new paradigm for managing malignant brain cancer. Nutrition & Metabolism, 2020
5. Poff AM et al. Ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One, 2013
6. Wallace DC. Mitochondria and cancer. Nature Reviews Cancer, 2012